Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world Conditions
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
Interventions
Sponsor
Sanofi
Collaborators